Therapeutic Areas of Interest

We are focused on areas that are in urgent need of innovation, and where our research has an immediate impact on the patient´s life.

We only study chronic illnesses that do not have a solution today, or where the current medical approach has a heavy impact on quality of life.


Diabetic Ophthalmology

Losing sight is one the biggest fears, yet realities, for diabetic patients.  

Despite the huge impact that blindness has on quality of life, ophthalmology remains one of the the worst managed complications in Diabetes.

The understanding of Diabetes changed from simply a vascular problem, to a neurological problem followed by a vascular one.

Yet, ophthalmic diagnostics still work by detecting only vascular damage.

Diabetic Retinopathy, for example, is only detected after irreversible damage has occurred. 

We wish to move the ophthalmic screening at least five years earlier, to its neurodegenerative stage.

This will allow for more treatment options that are far less aggressive.

Chronic Digestive Complications

Most chronic digestive complications are treated with an effective yet inefficient and out-dated technology (pancreatic digestive enzymes).

These enzymes are only active in the intestine at the very end of the digestive process.

Due to the chronic nature of the illnesses, patients’ intestines tend to be inflamed. 

We want to devise a solution to begin digestion earlier – in the stomach – alleviating most of the pain associated with digestive troubles, and more importantly, allowing the intestines to focus exclusively on nutrient absorbtion and on self-regeneration.